Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07522008Recruiting

ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms

Role: lead

NCT07507578Recruiting

A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma

Role: collaborator

NCT05756621Recruiting

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Role: collaborator

NCT06572826Recruiting

Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)

Role: collaborator

NCT04984785Completed

Lipid Metabolism in Obese Subjects Undergoing Bariatric Surgery

Role: collaborator

NCT03018535Phase 3Unknown

Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy

Role: collaborator

NCT02729584Completed

Gene Polymorphism of Taste Receptors and Circulating Endocannabinoids in Normal Weight and Obese Subjects

Role: collaborator

NCT02298413Unknown

Italian Absorb Registry

Role: collaborator

NCT01570270Phase 1Completed

Cheese Intake and Hypercholesterolemia

Role: lead

NCT01561846Phase 1Completed

Cheese Intake,CLA and Hypercholesterolemia

Role: lead

All 10 trials loaded